Obesity is directly related to the development of cardiometabolic disease (arterial hypertension, coronaric syndrome or heart failure (10) and in particular abdominal obesity is the most frequent component of metabolic syndrome along with T2D, dyslipidemia and hypertension (1113)
Think of it as the conductor of your body's antioxidant orchestra, coordinating and enhancing the protective effects of your entire antioxidant network
Clinical trials have extended beyond two years, and the safety profile appears acceptable for ongoing use
Gottlieb DJ, Lederer DJ, Kim JS, et al
In a diabetic retinopathy model, AST treatment elevated the levels of the antioxidant enzyme heme oxygenase-1 (HO-1) and preserved homeostasis for retinal ganglion cells (Yoshihisa et al., 2014)
The first thing to remember is that all of the clinical trials, GLP-1s were not tested against no treatment